Features

30 Sep 08

The period 2008-2023 will see a vaccine "boost". There will be a new resurgence in the sales and utilisation of vaccines. Are you prepared for this? You should be.
Editor

29 Sep 08

A new national guideline will provide clarity on emergency oxygen use in adults
Bansree Takodra

29 Sep 08

Sydney, Australia 29th September, 2008. A recent case heard in the Federal Court of Australia illustrates the need for comprehensive, accurate and regularly updated patent information to ensure that the planned launch of a generic pharmaceutical product is not delayed.
Trevor Giacomelli

26 Sep 08

Alzheimer's disease is the most common cause of dementia.
Editor

24 Sep 08

This months feature focus from PharmiWeb.com covers the difference between a common cold and flu, the various symptoms and recent preventions.
PharmiWeb Editor

23 Sep 08

- Examination of the UK, US and European regional markets for prescription pharmaceuticals 2008 -
Editor

22 Sep 08

The job of a medical sales rep. (drug rep, pharmaceutical sales rep) can be an exciting and rewarding one. So what can you do to get a job in this dynamic field?
Editor

19 Sep 08

If you are new to using PharmiWeb.com in your job searching, you'll soon realise that we have thousands of jobs listed and that they change every day. This means you may initially find the task a bit daunting.
Mike Wood

12 Sep 08

Frankly speaking, stop the guesswork and open heartedly accept that it's Google's turn now, as the next decade clearly belongs to Google, best not to resist and go with the flow.
Naseem Javed

08 Sep 08

With Google now being 10 years old, a leading medical protection organisation is highlighting the increasing trend towards patient using the search engine for online self-diagnosis.
Ciara Brannigan

08 Sep 08

Parkinson's is a progressive neurological condition affecting movements such as walking, talking, and writing. It is named after Dr. James Parkinson (1755-1824), the London doctor who first identified Parkinson's as a specific condition.
Parkinson's Disease Society

08 Sep 08

Survey finds 38% of GP practices are currently underprepared for a flu pandemic, and one in ten do not have any emergency recovery plans in place.
Stuart Gidden

05 Sep 08

All industries today face perpetual change and the need to cope with new challenges; nowhere is this trend more prevalent than in the life sciences industries, ie pharmaceuticals, biotech, diagnostics, medical devices and healthcare services.
Roger Anderson

02 Sep 08

Scientists have just announced the development of new medical imaging technology that can spot signs of osteoarthritis even before it starts causing joint damage.
Rita Dores

29 Aug 08

A child born in a Glasgow, Scotland suburb can expect a life 28 years shorter than another living only 13 kilometers away. A girl in Lesotho is likely to live 42 years less than another in Japan. In Sweden, the risk of a woman dying during pregnancy and childbirth is 1 in 17,400; in Afghanistan, the odds are 1 in 8.
WHO

15 Aug 08

The UK government have told kidney cancer patients that new drugs cannot be offered on the National Health Service. Roche's Avastin, Bayer's Nexavar, Pfizer's Sutent and Wyeth's Torisel were not cost-effective. The drugs known generically as bevacizumab, sorafenib, sunitinib and temsirolimus should therefore not be a treatment option for advanced and/or metastatic kidney cancer, NICE said.
Visiongain

14 Aug 08

This feature 'What is Eczema?' is one of three features that focuses on the topic of skin conditions.
Pharmiweb Editor

14 Aug 08

This feature 'What is Psoriasis?' is one of three features that focuses on the topic of skin conditions.
Pharmiweb Editor

13 Aug 08

Pfizer is recognised as being one of the strongest performing pharmaceutical companies in terms of sales, revenue growth, acquisitions, breadth of portfolio, product launches and pipeline developments. Pfizer's prominence is due to the company having nine blockbuster products, seven market leaders and strong products in all the major therapeutic categories. How can you compete with them? Which areas are the exposed in? Find out today in this new Visiongain report.
Mike Wood

13 Aug 08

This feature 'What is Acne?' is one of three features that focuses on the topic of skin conditions.
PharmiWeb Editor

30 Jul 08

The global clinical trials business is worth an estimated $50bn in 2008, with a rate of growth of 10%. In recent years, the nature of clinical trials has changed considerably. An increased emphasis has been placed on cost-effectiveness of pharmaceutical R&D, as well as increased productivity to maintain the high output of recent years.
Visiongain Editor

11 Jul 08

The development of innovative therapeutics and complimentary technologies for the effective management of pain 7th – 8th October 2008, BSG Conference Centre, London, UK.
PharmiWeb Editor

09 Jul 08

Arthritis is not just a disease of older people – it can affect people of all ages, including children. It is not clear what causes arthritis and there is no cure at present. However, there is plenty you can do to manage yourcondition and lead a full and active life.
PharmiWeb Editor

27 Jun 08

Finally a comprehensive source for the very latest performance metrics and trend analysis on every key aspect of the new drug approval processThe US Drug Approval Trends and Yearbook 2006/2007!
Rachel Thompson

23 Jun 08

In recent years Negative Pressure Wound Therapy has revolutionised the way clinicians manage and treat a wide range of wounds, Negative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment that uses controlled negative pressure to assist and accelerate wound healing (Bryant, R. 2000).
Kevin Mearns

17 Jun 08

Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis. Data presented at the Annual European Rheumatology Congress (EULAR) suggest that, in combination with methotrexate, Cimzia acts fast to significantly suppress disease activity, prevent structural damage to joints, preserve physical function and help patients continue working productively.
Olwen Glynn Owen - Pharmiweb Field reporter

12 Jun 08

Alzheimer disease (AD) is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness from a broad base of stake holders. With the grey population being the single most influencial factor in driving the economic growth within this sector, Visiongain believes the real market of the AD industry still remains untapped.
PharmiWeb Editor

09 Jun 08

Of patients with lung cancer, 80 per cent have non-small cell lung cancer (NSCLC) and of those, 40 per cent are not diagnosed until their disease is advanced and has spread to other organ sites. Current targeted treatment has improved survival but is not suitable for all. Now a new trial, FLEX, shows adding the targeted therapy Erbitux (cetuximab) to chemotherapy increases survival for all types of NSCLC.
Olwen Glynn Owen - PharmiWeb.com Field Reporter

09 Jun 08

The 'Scanning New Horizons in Rheumatoid Arthritis' Media Briefing is an innovative global press event featuring presentations by internationally renowned experts: Professor Paul Emery, Professor Robert Moots and Professor Bengt Jansson.
Editor

06 Jun 08

The EU GMPs were updated this year in February. As a result, Risk Management is a regulatory requirement and ICH Q9 is now Annex 20. EU regulators have also indicated that ICH Q10 on Pharmaceutical Quality Systems will become Annex 21 to the GMPs in June 2008 – sometime this month!
Belinda Chow